Skip to main navigation
Skip to search
Skip to main content
Universitat Autònoma de Barcelona Research Portal Home
Help & FAQ
Home
Profiles
Research Units
Projects
Research output
Search by expertise, name or affiliation
Emerging role of safinamide in Parkinson’s disease therapy
Jaime Kulisevsky
Department of Medicine
Research output
:
Contribution to journal
›
Review article
›
Research
›
peer-review
9
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Emerging role of safinamide in Parkinson’s disease therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Parkinson's Disease
100%
Safinamide
100%
Dopamine Agonist
60%
Dyskinesia
40%
Quality of Life
40%
Pharmacokinetics
20%
Substitution Therapy
20%
Combination Therapy
20%
Neurotransmission
20%
Levodopa
20%
Chemotherapeutic Agent
20%
Disease Management
20%
Drug
20%
Patient
20%
Therapeutic Procedure
20%
Water
20%
Mechanism of Action
20%
Medication
20%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson Disease
100%
Safinamide
100%
Dopamine Receptor Stimulating Agent
60%
Complication
40%
Dyskinesia
40%
Side Effect
40%
Levodopa
20%
Pharmacokinetics
20%
Normal Human
20%
Human
20%
Drug
20%
Animal
20%
Symptom
20%
Water
20%
Neuroscience
Parkinson's Disease
100%
Safinamide
100%
Dopaminergic
40%
Dyskinesia
40%
L-DOPA
20%
Dopamine Agonist
20%
Neurotransmission
20%
Pharmacokinetics
20%
Veterinary Science and Veterinary Medicine
Safinamide
100%
Dopaminergic
40%
Glutamatergic
20%
Psychology
Dopamine
20%
Treatment
20%
Humans
20%
Neurotransmission
20%